|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
4 February 2013 |
|
Main ID: |
NCT01207791 |
|
Date of registration:
|
21/09/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments
SMART-ED |
|
Scientific title:
|
Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments |
|
Date of first enrolment:
|
October 2010 |
|
Target sample size:
|
1285 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01207791 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Alyssa A Forcehimes, Ph.D. |
|
Address:
|
|
|
Telephone:
|
505-925-2399 |
|
Email:
|
aforcehimes@comcast.net |
|
Affiliation:
|
|
|
|
Name:
|
Michael P. Bogenschutz, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of New Mexico |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Registration as patient in the ED during study screening hours
2. Positive screen (=3) for problematic use of a non-alcohol, non-nicotine drug based on
the Drug Abuse Screening Test (DAST)
3. At least one day of problematic drug use (excluding alcohol and nicotine) in the past
30 days
4. Age 18 years or older
5. Adequate English proficiency
6. Ability to provide informed consent
7. Access to phone (for booster sessions)
Exclusion Criteria:
1. Inability to participate due to emergency treatment
2. Significant impairment of cognition or judgment rendering the person incapable of
informed consent. (e.g., traumatic brain injury, delirium, intoxication)
3. Status as a prisoner or in police custody at the time of treatment.
4. Current engagement in addiction treatment
5. Residence more than 50 miles from the location of follow-up visits
6. Inability to provide sufficient contact information (must provide at least 2 reliable
locators).
7. Prior participation in the current study.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Drug Abuse
|
|
Intervention(s)
|
|
Behavioral: assessment
|
|
Behavioral: booster sessions
|
|
Behavioral: Brief intervention
|
|
Behavioral: referral
|
|
Behavioral: screening
|
|
Primary Outcome(s)
|
|
days of use of the primary drug of abuse
[Time Frame: 30 days preceding 3-month follow-up]
|
|
Secondary Outcome(s)
|
|
days of heavy drinking
[Time Frame: 3, 6, 12 months]
|
|
Days of use of the primary drug of abuse
[Time Frame: 6 months, 12 months]
|
|
ED and other health care utilization
[Time Frame: 3, 6, 12 months]
|
|
number days abstinent from all drugs
[Time Frame: 3, 6, 12 months]
|
|
objective change in drug use based on analysis of hair samples
[Time Frame: 3, 6, 12 months]
|
|
percent entering treatment among those classified as having probable dependence
[Time Frame: 3, 6, 12 months]
|
|
self-reported consequences of drug and alcohol use
[Time Frame: 3, 6, 12 months]
|
|
total quantity of drug use
[Time Frame: 3, 6, 12 months]
|
|
Secondary ID(s)
|
|
NIDA CTN Protocol 0047
|
|
U10DA013732
|
|
U10DA015833
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|